Post doctoral researcher
School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Sydney, United States
Dr Claudia Bruno, PhD BSc (Hons 1), School of Population Health, UNSW Sydney, Australia
As a pharmacoepidemiologist, I use population-based data to examine the quality use of psychotropic medicines among priority populations. My research aims to promote best-practice healthcare through public health policy and clinical practice changes.
I am an early career researcher with the Medicines Intelligence (MedIntel) Research Program at the School of Population Health. Throughout my career, I have conducted extensive analyses of linked health data on national and international levels. I collaborate with the Nordic countries, at the Norwegian Public Health Institute in Oslo. This partnership enabled knowledge exchange and provided valuable insights into the safety of medicines in pregnancy and the analysis of multinational data.
I am passionate about using population-based linked data and sophisticated methods to provide evidence about real-world medicine use and outcomes. I am particularly interested in the safety and quality use of medicines among high-risk and under-served population groups, including pregnant women and children.
My Qualifications include:
PhD in Public Health and Community Medicine, UNSW Sydney 2020-2023
Thesis title: Using real-world data to generate evidence to improve quality use of psychotropic medicines in priority populations.
Bachelor of Science (Statistics and Physiology major), Honours in Medical Science, UNSW Sydney (2014-2018)
Thesis title: Proton pump inhibitor use in Australia: evaluating national quality use of medicines initiatives.
Disclosure information not submitted.
Wednesday, August 28, 2024
8:30 AM – 10:00 AM CEST